InflaRx NV (IFRX)
0.8648
+0.03
(+4.03%)
USD |
NASDAQ |
Feb 13, 14:13
InflaRx Free Cash Flow : -47.11M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| CDT Equity, Inc. | -15.13M |
| LENZ Therapeutics, Inc. | -46.16M |
| Liminatus Pharma, Inc. | -10.38M |
| Oruka Therapeutics, Inc. | -84.60M |
| Maze Therapeutics, Inc. | -108.03M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -11.30M |
| Cash from Investing (Quarterly) | 2.795M |
| Cash from Financing (Quarterly) | 0.8216M |
| Free Cash Flow Per Share (Quarterly) | -0.1684 |
| Free Cash Flow to Equity (Quarterly) | -11.84M |
| Free Cash Flow to Firm (Quarterly) | -11.39M |
| Free Cash Flow Yield | -84.56% |